{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T23:06:39Z","timestamp":1779577599478,"version":"3.53.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejso.2026.111803","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:02:07Z","timestamp":1776142927000},"page":"111803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conversion surgery after repeated intraperitoneal chemotherapy in unresectable peritoneal metastatic colorectal cancer: a narrative review of the literature"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7309-2573","authenticated-orcid":false,"given":"Alessia","family":"Scarton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun M.E.","family":"Kerkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-1429","authenticated-orcid":false,"given":"Felice N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-0186","authenticated-orcid":false,"given":"Jacobus W.A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sommariva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H.J.T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejso.2026.111803_bib1","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1245\/s10434-021-10190-z","article-title":"Treatment strategies and prognosis of patients with synchronous or metachronous colorectal peritoneal metastases: a population-based study","volume":"28","author":"Bakkers","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111803_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4292\/wjgpt.v7.i3.343","article-title":"Therapeutic options for peritoneal metastasis arising from colorectal cancer","volume":"7","author":"Glockzin","year":"2016","journal-title":"World J Gastrointest Pharmacol Therapeut"},{"key":"10.1016\/j.ejso.2026.111803_bib3","article-title":"Consensus guideline for the management of colorectal cancer with peritoneal metastases","volume":"25","author":"Schultz","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111803_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10585-023-10212-y","article-title":"Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study","volume":"40","author":"Rijken","year":"2023","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.ejso.2026.111803_bib5","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0102","article-title":"Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: surgeon's perspective","volume":"3","author":"Franko","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"8","key":"10.1016\/j.ejso.2026.111803_bib6","doi-asserted-by":"crossref","first-page":"O264","DOI":"10.1111\/codi.12560","volume":"16","author":"Hompes","year":"2014","journal-title":"Colorectal Dis"},{"issue":"8","key":"10.1016\/j.ejso.2026.111803_bib7","doi-asserted-by":"crossref","first-page":"O264","DOI":"10.1111\/codi.12560","article-title":"A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer","volume":"16","author":"Hompes","year":"2014","journal-title":"Colorectal Dis"},{"issue":"7","key":"10.1016\/j.ejso.2026.111803_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40265-025-02195-9","article-title":"A clinical pharmacological perspective on intraperitoneal chemotherapy","volume":"85","author":"Rietveld","year":"2025","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ejso.2026.111803_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtr\u00f6der","year":"2016","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.ejso.2026.111803_bib10","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2020-0109","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients","volume":"5","author":"Elleb\u00e6k","year":"2020","journal-title":"Pleura Peritoneum"},{"issue":"9","key":"10.1016\/j.ejso.2026.111803_bib11","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","article-title":"Pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase II trial (CRC-PIPAC)","volume":"28","author":"Rovers","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111803_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000203","article-title":"Treatment response after pressurized IntraPeritoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of colorectal originf","volume":"3","author":"H\u00fcbner","year":"2022","journal-title":"Ann Surg Open"},{"issue":"8","key":"10.1016\/j.ejso.2026.111803_bib13","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1245\/s10434-022-11577-2","article-title":"Feasibility and safety of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy with or without intraoperative intravenous 5-Fluorouracil and leucovorin for colorectal peritoneal metastases: a multicenter comparative cohort study","volume":"29","author":"Taibi","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111803_bib14","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1245\/s10434-023-13941-2","article-title":"Safety and efficacy of Oxaliplatin pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in colorectal and appendiceal cancer with peritoneal metastases: results of a multicenter phase I trial in the USA","volume":"30","author":"Raoof","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111803_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108487","article-title":"First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II)","volume":"50","author":"Rauwerdink","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111803_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejso.2019.06.028","article-title":"Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"47","author":"Alyami","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111803_bib17","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1245\/s10434-020-09332-6","article-title":"Pressurized intraperitoneal aerosol chemotherapy enhanced by electrostatic precipitation (ePIPAC) for patients with peritoneal metastases","volume":"28","author":"Taibi","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2026.111803_bib18","first-page":"1","article-title":"Feasibility and safety of Taxane-PIPAC in patients with peritoneal Malignancies-a retrospective Bi-institutional study","volume":"14","author":"Mehta","year":"2022","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111803_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12029-022-00843-x","article-title":"Oncological outcomes after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of peritoneal carcinomatosis","volume":"54","author":"Tidadini","year":"2023","journal-title":"J Gastrointest Cancer"},{"issue":"24","key":"10.1016\/j.ejso.2026.111803_bib20","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/cancers16244229","article-title":"Efficacy and insights from an extensive series of cytoreductive surgery for peritoneal neoplasms: a high-volume single-center experience","volume":"16","author":"Aulicino","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ejso.2026.111803_bib21","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/cancers17121938","article-title":"Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) for peritoneal malignancies with palliative and bidirectional intent","volume":"17","author":"Marrelli","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111803_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2025.102293","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal malignancies: a monocentric, single-arm open-label phase II clinical trial","volume":"63","author":"Tonello","year":"2025","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111803_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/pp-2016-0018","article-title":"Preoperative intraperitoneal oxaliplatin for unresectable peritoneal carcinomatosis of colorectal origin: a pilot study","volume":"1","author":"Sgarbura","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"11","key":"10.1016\/j.ejso.2026.111803_bib24","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/bjs\/znad228","article-title":"Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases","volume":"110","author":"van Eerden","year":"2023","journal-title":"Br J Surg"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2026.111803_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s13193-023-01715-x","article-title":"Bidirectional chemotherapy in advanced colorectal cancer peritoneal metastases","volume":"14","author":"Chatterjee","year":"2023","journal-title":"Indian J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.111803_bib26","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1245\/s10434-025-17106-1","article-title":"Repeat diagnostic laparoscopy after chemotherapy is useful in patient selection for conversion to cytoreductive surgery for initially unresectable colorectal and appendiceal peritoneal metastases: a retrospective cohort study","volume":"32","author":"Gohda","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111803_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the peritoneal regression grading score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"10.1016\/j.ejso.2026.111803_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077667","article-title":"Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial","volume":"14","author":"van de Vlasakker","year":"2024","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ejso.2026.111803_bib29","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/cancers15041125","article-title":"10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis","volume":"15","author":"Di Giorgio","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.ejso.2026.111803_bib30","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/cancers16213661","article-title":"Pressurized intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a systematic review of the evidence","volume":"16","author":"Sleiman","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejso.2026.111803_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00280-018-3714-5","article-title":"Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial","volume":"83","author":"Murono","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111803_bib32","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1007\/s00464-021-08802-6","article-title":"Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)","volume":"36","author":"Lurvink","year":"2022","journal-title":"Surg Endosc"},{"issue":"11","key":"10.1016\/j.ejso.2026.111803_bib33","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1007\/s00464-024-11185-z","article-title":"Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II)","volume":"38","author":"van de Vlasakker","year":"2024","journal-title":"Surg Endosc"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2026.111803_bib34","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.21037\/jgo-20-257","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review","volume":"12","author":"Lurvink","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111803_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae116","article-title":"Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis","volume":"111","author":"Guchelaar","year":"2024","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111803_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00423-024-03374-0","article-title":"Prognosis and predictive factors of conversion surgery for initially unresectable advanced colorectal cancer","volume":"409","author":"Ohira","year":"2024","journal-title":"Langenbecks Arch Surg"},{"issue":"12","key":"10.1016\/j.ejso.2026.111803_bib37","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s11095-025-03917-0","article-title":"Physiological considerations and delivery strategies for targeting tumors through intraperitoneal delivery","volume":"42","author":"Jony","year":"2025","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.ejso.2026.111803_bib38","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00384-020-03649-0","article-title":"Efficacy of intraperitoneally administered paclitaxel for colorectal cancer with peritoneal metastases","volume":"35","author":"Murono","year":"2020","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"10.1016\/j.ejso.2026.111803_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10585-018-9895-9","article-title":"Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey","volume":"35","author":"Graversen","year":"2018","journal-title":"Clin Exp Metastasis"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T22:58:52Z","timestamp":1779577132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326004221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0748798326004221"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111803","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion surgery after repeated intraperitoneal chemotherapy in unresectable peritoneal metastatic colorectal cancer: a narrative review of the literature","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111803"}}